Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medium-term bioassays as alternative carcinogenicity test

N Ito1, K Imaida, S Tamano

  • 1Nagoya City University, Nagoya City University Medical School, Japan.

The Journal of Toxicological Sciences
|October 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pretreatment ADC Histogram Analysis as a Prognostic Imaging Biomarker for Patients with Recurrent Glioblastoma Treated with Bevacizumab: A Systematic Review and Meta-analysis.

AJNR. American journal of neuroradiology·2022
Same author

Sodium MR Neuroimaging.

AJNR. American journal of neuroradiology·2021
Same author

Constraints on Cosmic Strings Using Data from the Third Advanced LIGO-Virgo Observing Run.

Physical review letters·2021
Same author

3D Quantitative Synthetic MRI in the Evaluation of Multiple Sclerosis Lesions.

AJNR. American journal of neuroradiology·2021
Same author

Prospects for observing and localizing gravitational-wave transients with Advanced LIGO, Advanced Virgo and KAGRA.

Living reviews in relativity·2020
Same author

Myelin and Axonal Damage in Normal-Appearing White Matter in Patients with Moyamoya Disease.

AJNR. American journal of neuroradiology·2020

Developed medium-term bioassays rapidly detect carcinogenic agents in rats, offering a faster alternative to long-term tests. These validated systems are crucial for carcinogenicity risk assessment and evaluating chemopreventive agents.

Area of Science:

  • Toxicology and Carcinogenesis
  • In vivo Bioassays
  • Drug Safety and Risk Assessment

Background:

  • Existing carcinogenicity tests are time-consuming and costly.
  • A need exists for rapid, reliable methods to screen chemicals for carcinogenic potential.
  • The two-stage hypothesis of carcinogenesis provides a framework for developing predictive bioassays.

Purpose of the Study:

  • To develop and validate medium-term bioassay systems for the rapid detection of carcinogenic agents.
  • To provide alternative testing strategies for carcinogenicity risk assessment.
  • To evaluate the efficacy of chemopreventive agents and study dose-response relationships.

Main Methods:

  • A liver bioassay using male F344 rats with diethylnitrosamine initiation and partial hepatectomy, followed by test chemical administration.

Related Experiment Videos

  • A multiorgan bioassay using multiple chemical carcinogens (DEN, MNU, BBN, DMH, DHPN) to assess carcinogenicity across various organs.
  • Quantitative analysis of glutathione S-transferase placental form positive hepatic foci and histological examination of major organs.

    • Main Results:

    • The liver bioassay system has been validated through the analysis of 291 chemicals, establishing its efficacy for hepatocarcinogens.
    • The multiorgan bioassay system successfully detects both hepatocarcinogens and other organ-specific carcinogens.
    • These bioassays are recognized as valuable and appropriate alternative methods for carcinogenicity risk assessment.

    Conclusions:

    • Medium-term bioassays offer a rapid and effective approach for detecting carcinogenic agents in vivo.
    • These systems are suitable for dose-response studies, chemical mixture evaluations, and chemopreventive agent testing.
    • The International Conference on Harmonization has proposed these bioassays as additional in vivo tests for carcinogenic activity.